Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the objective response rate (ORR) of SAR240550 administered as a 60min intravenous infusion twice weekly (arm A) or weekly (arm B), in combination with gemcitabine/carboplatin chemotherapy regimen in patients with metastatic Triple Negative Breast Cancer (mTNBC)
Inclusion criteria
- Metastatic Triple Negative Breast Cancer